Literature DB >> 17222742

Alpha2cDel322-325 and beta1Arg389 adrenergic polymorphisms are not associated with reduced left ventricular ejection fraction or increased left ventricular volume.

Russell M Canham, Sandeep R Das, David Leonard, Shuaib M Abdullah, Sameer K Mehta, Anne K Chung, Jia-Ling Li, Ronald G Victor, Richard J Auchus, Mark H Drazner.   

Abstract

Mesh：

Substances：

Year:  2006        PMID： 17222742     DOI： 10.1016/j.jacc.2006.10.016

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN： 0735-1097            Impact factor:   24.094


× No keyword cloud information.
  10 in total

1.  Left atrial structure and function and clinical outcomes in the general population.

Authors:  Sachin Gupta; Susan A Matulevicius; Colby R Ayers; Jarett D Berry; Parag C Patel; David W Markham; Benjamin D Levine; Kelly M Chin; James A de Lemos; Ronald M Peshock; Mark H Drazner
Journal:  Eur Heart J       Date:  2012-07-10       Impact factor: 29.983

2.  Loss-of-function DNA sequence variant in the CLCNKA chloride channel implicates the cardio-renal axis in interindividual heart failure risk variation.

Authors:  Thomas P Cappola; Scot J Matkovich; Wei Wang; Derek van Booven; Mingyao Li; Xuexia Wang; Liming Qu; Nancy K Sweitzer; James C Fang; Muredach P Reilly; Hakon Hakonarson; Jeanne M Nerbonne; Gerald W Dorn
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-19       Impact factor: 11.205

Review 3.  The genomic architecture of sporadic heart failure.

Authors:  Gerald W Dorn
Journal:  Circ Res       Date:  2011-05-13       Impact factor: 17.367

Review 4.  Practical recommendations for the use of beta-blockers in chronic obstructive pulmonary disease.

Authors:  Chad Wade; J Michael Wells
Journal:  Expert Rev Respir Med       Date:  2020-04-19       Impact factor: 3.772

Review 5.  Race, common genetic variation, and therapeutic response disparities in heart failure.

Authors:  Mathew R Taylor; Albert Y Sun; Gordon Davis; Mona Fiuzat; Stephen B Liggett; Michael R Bristow
Journal:  JACC Heart Fail       Date:  2014-10-22       Impact factor: 12.035

6.  The Arg16Gly-β(2)-adrenoceptor single nucleotide polymorphism: exercise capacity and survival in patients with end-stage heart failure.

Authors:  Kirsten Leineweber; Ulrich H Frey; Gero Tenderich; Mohammad Reza Toliat; Armin Zittermann; Peter Nürnberg; Reiner Körfer; Winfried Siffert; Gerd Heusch
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2010-08-29       Impact factor: 3.000

7.  Association of an intronic, but not any exonic, FRMD4B sequence variant and heart failure.

Authors:  Scot J Matkovich; Derek J Van Booven; Thomas P Cappola; Gerald W Dorn
Journal:  Clin Transl Sci       Date:  2010-08       Impact factor: 4.689

8.  The alpha2C-adrenoceptor deletion322-325 variant and cold-induced vasoconstriction.

Authors:  Eitan A Friedman; Paul A Harris; Alastair J J Wood; C Michael Stein; Daniel Kurnik
Journal:  Clin Auton Res       Date:  2009-05-15       Impact factor: 4.435

9.  Genetic variants in the alpha2C-adrenoceptor and G-protein contribute to ethnic differences in cardiovascular stress responses.

Authors:  Daniel Kurnik; Eitan A Friedman; Mordechai Muszkat; Gbenga G Sofowora; Hong-Guang Xie; William D Dupont; Alastair J J Wood; C Michael Stein
Journal:  Pharmacogenet Genomics       Date:  2008-09       Impact factor: 2.089

10.  The alpha 2C Del322-325 adrenergic receptor polymorphism is not associated with heart failure due to idiopathic dilated cardiomyopathy in black Africans.

Authors:  J Du Preez; L O Matolweni; J Greenberg; P Mntla; A A Adeyemo; B M Mayosi
Journal:  Cardiovasc J Afr       Date:  2008 Jan-Feb       Impact factor: 1.167
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.